STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

A new phase 3 clinical trial called PROTEUS found that combining two hormone therapies before and after surgery improved outcomes for high-risk, early-stage prostate cancer patients compared to one hormone therapy. Some oncologists view this as a potential new standard of care, though interpretations of the results vary.